News
Clinical Trials Arena on MSN3d
IO Biotech to pursue cancer vaccine approval despite Phase III miss
Cylembio did not meet its primary endpoint of progression-free survival (PFS), but did demonstrate a trend towards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback